Добавил:
ivanov666
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Аспергиллез легких
.pdf
Halweg H., Traczyk K., Walczak J. et al. Late results of the local treatment of single pulmo
nary aspergilloma with antifungal pastes. — Pneumonol Pol, 1983, vol. 51(8–9),
p. 461–468 (Polish).
Halweg H., Ciszek J., Krakowka P. The reversal of serological reactions in patients with
pulmonary and pleural aspergillosis after treatment. — Tubercle, 1968, vol. 49,
p. 404–409.
Hammerman K., Sarosi G., Tosh F. Amphotericin B in the treatment of saprophytic forms
of pulmonary aspergillosis. — Am Rev Respir Dis, 1974, vol. 109(1), p. 57–62.
Hanagiri T., Okabayashi K., Mitsudomi T. et al. Aspergilloma within cavitating pulmonary
carcinoma. Case report. — Scandinavian Journal of Thoracic & Cardiovascular Sur
gery, 1993, vol. 27(1), p. 57–60.
Hargis J., Bone R., Stewart J. et al. Intracavitary amphotericin  in the treatment of symp
tomatic pulmonary aspergillomas. — Am J Med, 1980, vol. 68, p. 89–94.
Hashimoto M., Honda Y., Fujishima T. Successful treatment by voriconazole for pulmona
ry aspergilloma of elderly patient. — Nihon Kokyuki Gakkai Zasshi, 2007, vol. 45(12),
p. 957–961.
Hebart H., Loffler J., Reitze H. et al. Prospective screening by a panfungal polymerase
chain reaction assay in patients at risk for fungal infections: implications for the mana
gement of febrile neutropenia. — Br J Haematol, 2000, vol. 111(2), p. 35–40.
Heidemann H., Gerkens J., Spickard W. et al. Amphotericin B nephrotoxicity in humans
decreased by salt repletion. — Am J Med, 1983, vol. 75(3), p. 476–481.
Henderson A., English M., Vecht J. Pulmonary aspergillosis. A survey of its occurence in
patients with chronic lung disease and a discussion of the significance of diagnostic
tests. — Thorax, 1968, vol. 23, p. 513–518.
Hirano K., Saitoh T., Kadono K. et al. Conversion of chronic necrotizing pulmonary asper-
gillosis to invasive pulmonary aspergillosis, and successful treatment with fluconazole. — Nihon Kyobu Shikkan Gakkai Zasshi, 1997, vol. 35(4), p. 408–413.
Hope W., Petraitis V., Petraitiene R. et al. The initial 96 hours of invasive pulmonary asper
gillosis: histopathology, comparative kinetics of galactomannan and (1, 3) b-d-glucan
and consequences of delayed antifungal therapy. — Antimicrob Agents Chemother,
2010, vol. 54(11), p. 4879–4886.
Horger M., Hebart H., Einsele H. et al. Initial CT manifestations of invasive pulmonary as
pergillosis in 45 non-HIV immunocompromised patients: association with patient out
come? — Eur J Radiol, 2005, vol. 55(3), p. 437–444.
Hornung V., Rothenfusser S., Britsch S. et al. Quantitative expression of toll-like receptor
1–10 mRNA in ñellular subsets of human peripheral blood mononuclear cells and sen
sitivity to CpG oligodeoxynucleotides. — J Immunol, 2002, vol. 168(9), p. 4531–4537.
Horvath J., Dummer S. The use of respiratory tract cultures in the diagnosis of invasive as
pergillosis. — Am J Med, 1996, vol. 100, p. 171–178.
Hoshino H., Tagaki S., Kon H. et al. Allergic bronchopulmonary aspergillosis due to Asper
gillus niger without bronchial asthma. — Respiration, 1999, vol. 66(4), p. 369–372.
Hsieh C., Macatonia S., Tripp C. et al. Development of TH1 CD4+ T cells through IL-12
produced by Listeria-induced macrophages. — Science, 1993, vol. 260, p. 547–549.
Huang C., Lee M., Lu R. et al. A case of pulmonary aspergilloma and actinomycosis. —
J Med Microbiol, 2011, vol. 60(Pt 4), p. 543–546.
-
-
-
-
-
-
-
-
-
-
-
171
Huffnagle G. Coevolution of TH1, TH2, and TH17 responses during repeated pulmonary
exposure to Aspergillus fumigatus conidia. — Infect Immun, 2011, vol. 79(1),
p. 125–135.
Iadarola P., Lungarella G., Martorana P. et al. Lung injury and degradation of extracellular
matrix components by Aspergillus fumigatus serine proteinase. — Exp Lung Res,
1998, vol. 24(3), p. 233–251.
Iadarola P., Lungarella G., Martorana P. et al. Phagocytosis and intracellular fate of Asper
gillus fumigatus conidia in alveolar macrophages. — Infect Immun 2003, vol. 71(2),
p. 891–903.
Ibrahim-Granet O., Philippe B., Boleti H. et al. Phagocytosis and intracellular fate of Asper
gillus fumigatus conidia in alveolar macrophages. — Infect Immun, 2003, vol. 71(2),
p. 891–903.
Inoue K., Koike E., Yanagisawa R. et al. Pulmonary exposure to soluble cell wall beta-(1,
3)-glucan of aspergillus induces proinflammatory response in mice. — Int J Immuno
pathol Pharmacol, 2009, vol. 22(2), p. 287–297.
Ivanov I., McKenzie B., Zhou L. et al. The orphan nuclear receptor RORãt directs the diffe
rentiation program of proinflammatory IL-17
+
T helper cells. — Cell, 2006, vol. 126,
p. 1121–1133.
Izumikawa K., Yamamoto Y., Mihara T. et al. Bronchoalveolar lavage galactomannan for
the diagnosis of chronic pulmonary aspergillosis. — Med Mycol, 2012, May 9 [Epub
ahead of print].
J Lab Clin Med, 1991, vol. 117(2), p. 138–142.
Jaillon S., Peri G., Delneste Y. et al. The humoral pattern recognition receptor PTX3 is sto-
red in neutrophil granules and localizes in extracellular traps. — J Exp Med, 2007,
vol. 204(4), p. 793–804.
Jewkes J., Kay P., Paneth M., Citron K. Pulmonary aspergilloma: analysis of prognosis in
relation to haemoptysis and survey of treatment. — Thorax, 1983, vol. 38, p. 572–578.
Jia H., Schutte B., Schudy A. et al. Discovery of new human beta-defensins using a geno
mics-based approach. — Gene, 2001, 263(1–2), p. 211–218.
Johard V., Eklund A., Dahiqvist M. et al. Sings of alveolar inflammation in non-smoking
Swedish wood trimmers. — British J. of Industrial Medicine, 1992, vol. 49(6),
p. 428–434.
Just-Nubling G., Ganger G., Keul H. et al. Invasive aspergillus infections (IA) in AIDS: a ri
sing problem in Frankfurt. — 8
th
International Conference on AIDS, 1992, Amsterdam.
Abstract PoB 3337.
Kabiri H., Lahlou K., Achir A. et al. Pulmonary aspergilloma: results of surgical treatment.
Report of a series of 206 cases. — Chirurgie, 1999, vol. 124(6), p. 655–660.
Kaestel M., Meyer W., Mittelmeier H. et al. Pulmonary aspergilloma — clinical findings ahd
surgical treatment. — Thorac Cardiovasc Surg, 1999, vol. 47(5), p. 340–345.
Kahn F., Jones J., England D. The role of bronchoalveolar lavage in the diagnosis of inva
sive pulmonary aspergillosis. — Am J Clin Path, 1986, vol. 86, p. 5185–5223.
Kamamura S., Maesaki S., Tomono K. et al. Clinical evauation of 61 patient with pulmona
ry aspergilloma. — Intern Med, 2000, vol. 39(3), p. 209–212.
Kamberi M., Brummer E., Stevens D. Regulation of bronchoalveolar macrophages proinfl
ammatory cytokine production by dexamethasone and granulocyte-macrophage co
-
-
-
-
-
-
-
-
-
172
lony stimulating factor after stimulation by Aspergillus conidida or lipopolysaccarhi
de. — Cytokine 2002, vol. 19, p. 14–20.
Kao C., Chen Y., Zhao Y., Wu R. ORFeome-based search of airway epithelial cell-specific
novel human (beta)-defensin genes. — Am J Respir Cell Mol Biol, 2003, vol. 29(1),
p. 71–80.
Karageorgopoulos D., Qu J., Korbila I. et al. Accuracy of b-d-glucan for the diagnosis of
Pneumocystis jiroveciipneumonia: a meta-analysis. — Clin MicrobiolInfect, 2011 Dec
29. doi: 10.1111/j.1469–0691.2011.03760.x [Epub ahead of print].
Katila M.-L., Mantyjarvi R. The diagnostic value of antybodies to the traditional antigens of
farmer’s lung in Finland. — Clin Allergy, 1978, vol. 8, p. 581–587.
Kato T., Usami I., Morita H. et al. Chronic necrotizing pulmonary aspergillosis in pneumo
coniosis: clinical and radiologic findings in 10 patients. — Chest, 2002, vol. 121(1),
p. 118–127.
Kauffman C., Wilson K., Schwartz D. Necrotizing pulmonary aspergillosis with oxalosis. —
Mycozen, 1984, vol. 27(2), p. 535–538.
Kauffman H., Tomee J., van de Riet M. et al. Protease-dependent activation of epithelial
cells by fungal allergens leads to morphologic changes and cytokine production. —
J Allergy Clin Immunol, 2000, vol. 105(6 Pt 1), p. 1185–1193.
Kauffman H., Tomee J., van der Werf T. et al. Review of fungus-induced asthmatic reacti-
ons. — Am. J. of Respir. and Critical Care Medicine, 1995, vol. 151(6), p. 2109–2115.
Kaur S.,Gupta V., Thiel S. et al. Protective role of mannan-binding lectin in a murine model
of invasive pulmonary aspergillosis. — Clin Exp Immunol 2007, vol. 148, p. 382–389 .
Kawamura S., Maesaki S., Omagari K. et al. Invasive pulmonary aspergillosis diagnosed
early by polymerase chain reaction assay. — Intern Med, 1999, vol. 38(9), p. 744–746.
Kawamura S., Maesaki S., Tomono K. et al. Clinical evaluation of 61 patients with pulmo-
nary aspergilloma. — Intern Med, 2000, vol. 39(3), p. 209–212.
Kemper C., Hostetler J., Follansbee S. et al. Ulcerative and plaque-like tracheobronchitis
due to infection with Aspergillus in patients with AIDS. — Clin Infect Dis, 1993,
vol. 17(3), p. 344–352.
Kerrigan A., Brown G. C-type lectins and phagocytosis. — Immunobiology, 2009,
vol. 214(7), p. 562–575.
Kim J., Rhee Y., Kang S. et al. A case of endobronchial aspergilloma. — Yosei Med, 2000,
vol. 41, p. 411–425.
Kleinschmidt-DeMasters B. Central nervous system aspergillosis: a 20-year retrospective
series. — Hum Pathol, 2002, vol. 33(1), p. 116–124.
Knutsen A., Raymond G. Slavin Allergic Bronchopulmonary Aspergillosis in Asthma and
Cystic Fibrosis. — Clin Dev Immunol, 2011, vol. 843763. doi: 10.1155/2011/843763.
Kohno S., Izumikawa K., Kakeya H. et al. Clinical efficacy and safety of micafungin in Ja
panese patients with chronic pulmonary aspergillosis: a prospective observational
study. — Med Mycol, 2011, vol. 49(7), p. 688–693.
Kohno S., Izumikawa K., Ogawa K. et al. Japan Chronic Pulmonary Aspergillosis Study
Group JCPASG). Intravenous micafungin versus voriconazole for chronic pulmonary
aspergillosis: a multicenter trial in Japan. — J Infect, 2010, vol. 61(5), p. 410–418.
Kohno S., Masaoka T., Yamaguchi H. A multicenter, open-label clinical study of micafun
gin (FK463) in the treatment of deep-seated mycosis in Japan. — Scand J Infect Dis,
2004; vol. 36(5), p. 372–379.
-
-
-
-
173
Kontoyiannis D., Lewis R., Sagar N. et al. Itraconazole-Amphotericin B Antagonism in As
pergillus fumigatus: an E-Test-Based Strategy. — Antimicrobial Agents and Chemot
herapy, 2000, vol. 44(10), p. 2915–2918.
Koo S., Bryar J., Baden L., Marty F. Prognostic features of galactomannan antigenemia in
galactomannan-positive invasive aspergillosis. — J Clin Microbiol, 2010, vol. 48(4),
p. 1255–1260.
Korfhagen T. Surfactant protein-d enhances phagocytosis and pulmonary clearance of
respiratory syncytial virus. — Am J Respir Cell Mol Biol, 2004, vol. 31(2), p. 193–199.
Kousha M., Tadi R., Soubani A. Pulmonary aspergillosis: a clinical review. — Eur Res
Rev, 2011, vol. 20, p. 156–174.
Krarup A., Thiel S., Hansen A. et al. L-ficolin is a pattern recognition molecule specific for
acetyl groups. — J Biol Chem, 2004, vol. 279(46), p. 47513–47519.
Kumar R., Gaur S. Prevalence of allergic bronchopulmonary aspergillosis in patients with
bronchial asthma. — Asian Pac J Allergy Immunol, 2000, vol. 18(4), p. 181–185.
Kuroki Y., Takahashi M., Nishitani C. Pulmonary collectins in innate immunity of the
lung. — Cell Microbiol, 2007, vol. 9, ð. 1871–1879.
Kurup V.,Xia J., Crameri R. et al. Purified recombinant A. fumigatus allergens induce diffe
rent responses in mice. — Clin Immunol, 2001, vol. 98(3), p. 327–336.
Lamoth F., Rubino I., Bochud P. Immunogenetics of invasive aspergillosis. — Med Mycol,
2011, vol. 49, Suppl 1, p. 125–136.
Latge J. Aspergillus fumigatus and aspergillosis. — Clinical Microbiol Rev, 1999,
vol. 12(2), p. 310–350.
Le Gros G., Ben-Sasson S., Seder R. et al. Generation of interleukin 4 (IL-4)-producing
cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4-producing cells. — J Exp Med, 1990, vol. 172, p. 921–929.
Le Rochais J., Icard P., Simon T. et al. Bronchial stump aspergillosis. — Ann Thorac Surg,
2000, vol. 70(1), p. 302–304.
Leal S., Jr., Cowden S., Hsia Y. et al. Distinct roles for Dectin-1 and TLR4 in the pathoge
nesis of Aspergillus fumigatus keratitis. — PLoS Pathog, 2010, vol. 6, p. 100–976.
Lejay A., Falcoz P., Santelmo N. et al. Surgery for aspergilloma: time trend towards impro
ved results? — Interact Cardiovasc Thorac Surg, 2011, vol. 13(4), p. 392–395.
Leser C., Kauffman H., Virchow C., Sr., Menz G. Specific serum immunopatterns in clini
cal phases of allergic bronchopulmonary aspergillosis. — J Allergy Clin Immunol,
1992, vol. 90(4 Pt 1), p. 589–599.
LeVine A., Elliott J., Whitsett J. et al. Surfactant protein-d enhances phagocytosis and pul
monary clearance of respiratory syncytial virus. — Am J Respir Cell Mol Biol, 2004,
vol. 31(2), p. 193–199.
Levitz S., Selsted M., Ganz T. et al. In vitro killing of spores and hyphae of Aspergillus fu
migatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalve
olar macrophages. — J Infect Dis, 1986, vol. 154(3), p. 483–489.
Levy H., Horak D., Tegtmeier B. et al. The value of bronchoalveolar lavage and bronchial
washings in the diagnosis of invasive pulmonary aspergillosis. — Respir Med, 1992,
vol. 86, p. 243–248.
Lewis R. E., Kontoyiannis D. P. Rationale for Combination Antifungal Therapy. — Phar
macotherapy, 2001, vol. 21, p. 149–164.
-
-
-
-
-
-
-
-
-
-
174
Liu Y., Endo Y., Iwaki D. et al. Human M-ficolin is a secretory protein that activates the lec
tin complement pathway. — J Immunol, 2005, vol. 175(5), p. 3150–3156.
Longbottom J., Pepys J. Pulmonary aspergillosis: Diagnostic and immunological signifi
cances of antigens and C-substance in Aspergillus fumigatus. — J Path Bact, 1964,
vol. 88, p. 141–143.
Luther K., Torosantucci A., Brakhage A. et al. Phagocytosis of Aspergillus fumigatus coni
dia by murine macrophages involves recognition by the dectin-1 beta-glucan receptor
and Toll-like receptor 2. — Cell Microbiol, 2007, vol. 9(2), p. 368–381.
Ma Y., Cho M., Zhao M. et al. Human mannose-binding lectin and L-ficolin function as spe
cific pattern recognition proteins in the lectin activation pathway of complement. —
J Biol Chem, 2004, vol. 279(24), p. 25307–25312.
Ma Y., Doni A., Hummelshoj T. et al. Synergy between ficolin-2 and pentraxin 3 boosts inna
te immune recognition and complement deposition. — J Biol Chem, 2009, vol. 284(41),
p. 28263–28275.
Macperson P. Pulmonary aspergillosis in Argill. — Br J Dis Chest, 1965, vol. 59, p. 148–157.
Madan T., Eggleton P., Kishor U. et al. Binding of pulmonary surfactant proteins A and D to
Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrop
hils and alveolar macrophages. — Infect Immun 1997, vol. 65, p. 3171–3179.
Madan T., Kishore U., Singh M. et al. Protective role of lung surfactant protein D in a muri-
ne model of invasive pulmonary aspergillosis. — Infect Immun, 2001, vol. 69(4),
p. 2728–2731.
Madan T., Reid K., Clark H. et al. Susceptibility of mice genetically deficient in SP-A or
SP-D gene to invasive pulmonary aspergillosis. — Mol Immunol, 2010, vol. 47(10),
p. 1923–1930.
Madan T., Arora N., Sarma P. Identification and evaluation of a major cytotoxin of A. fumi-
gatus. — Mol Cell Biochem, 1997, vol. 167, p. 89–97.
Maertens J., Glasmacher A., Herbrecht R. et al. Caspofungin Combination Therapy Study
Group. Multicenter, noncomparative study of caspofungin in combination with other
antifungals as salvage therapy in adults with invasive aspergillosis. — Cancer, 2006,
vol. 107(12), p. 2888–2897.
Maertens J., Raad I., Petrikkos G. et al. Caspofungin Salvage Aspergillosis Study Group.
Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients
refractory to or intolerant of conventional antifungal therapy. — Clin Infect Dis, 2004,
vol. 39(11), p. 1563–1571.
Mambula S.,Sau K., Henneke P. et al. Toll-like receptor (TLR) signaling in response to As
pergillus fumigatus. — J Biol Chem 2002, vol. 277, p. 39320–39326.
Mangan P., Harrington L., O’Quinn D. et al. Transforming growth factor-â induces deve
lopment of the T(H)17 lineage. — Nature, 2006, vol. 441, p. 231–234.
Marghli A., Zairi S., Osmen M. et al. Conservative surgery in pulmonary aspergilloma. —
Rev Mal Respir, 2012, vol. 29(3), p. 384–390.
Marr K., Carter R., Boeckh M. et al. Invasive aspergillosis in allogeneic stem cell transplant
recipients: changes in epidemiology and risk factors. — Blood, 2002, vol. 100(13),
p. 4358–4366.
Marr K., Crippa F., Leisenring W. et al. Itraconazole versus fluconazole for prevention of
fungal infections in patients receiving allogeneic stem cell transplants. — Blood, 2004,
vol. 103(4), p. 1527–1533.
-
-
-
-
-
-
-
-
175
Marr K., Leisenring W. Design issues in studies evaluating diagnostic tests for aspergillo
sis. — Clin Infect Dis, 2005, vol. 41, Suppl 6, p. 381–386.
Marr K. Diagnosis of invasive aspergillosis. http:/uptodate.com (Accessed on Mar 2012).
Marr K. Epidemiology and clinical manifestation of invasive aspergillosis. http:/uptoda
te.com (Accessed on Mar 2012).
Marr K. Treatment and prevention of invasive aspergillosis. http:/uptodate.com (Accessed
on Apr 2012).
Maurya V., Gugnani H., Sarma P. et al. Sensitization to Aspergillus antigens and occur
rence of allergic bronchopulmonary aspergillosis in patients with asthma. — Chest,
2005, vol. 127(4), p. 1252–1259.
Meier A.,Kirschning C., Nikolaus T. et al. Toll-like receptor (TLR) 2 and TLR4 are essential
for Aspergillus-induced activation of murine macrophages. — Cell Microbiol 2003,
vol. 5, p. 561–570.
Mengoli C., Cruciani M., Barnes R. et al. Use of PCR for diagnosis of invasive aspergillo
sis: systematic review and meta-analysis. — Lancet Infect Dis, 2009, Feb, 9(2),
p. 89–96. Review. Erratum in: Lancet Infect Dis, 2009, vol. 9(5), p. 280.
Mennink-Kersten M., Donnelly J., Verweij P. Detection of circulating galactomannan for
the diagnosis and management of invasive aspergillosis. — Lancet Infect Dis, 2004,
vol. 4(6), p. 349–357.
Menzies D., Holmes L., McCumesky G. et al. Aspergillus sensitization is associated with
airflow limitation and bronchiectasis in severe asthma. — Allergy, 2011, vol. 66(5),
p. 679–685.
Metchers W., Verweij P., Van Den Hurk P. et al. General primer-mediated PCR for detecti-
on of Aspergillus species. — J Clin Microbiol, 1994, vol. 15, p. 11446–11452.
Mezger M., Kneitz S., Wozniok I. et al. Proinflammatory response of immature human
dendritic cellsis mediated by dectin-1 after exposureto Aspergillus fumigatus germ tubes. — J Infect Dis, 2008, vol. 197(6), p. 924–931.
Miceli M., Grazziutti M., Woods G. et al. Strong correlation between serum aspergillus ga
lactomannan index and outcome of aspergillosis in patients with hematological cancer:
clinical and research implications. — Clin Infect Dis, 2008, vol. 46(9), p. 1412–1422.
Moalli F., Doni A., Deban L. et al. Role of complement and Fc{gamma} receptors in the
protective activity of the long pentraxin PTX3 against Aspergillus fumigatus. — Blood,
2010, vol. 116(24), p. 5170–5180.
Monod M., Jaton-Ogay K., Reichard U. Aspergillus fumigatus-secreted proteases as anti
genic molecules and virulence factors. — Contrib Microbiol, 1999, vol. 2, p. 182–192.
Morgenstern G., Prentice A., Prentice H. et al. Fluconazole vs itraconazole for antifungal
prophylaxys in neutropenic patients. Abstr. Trends in Invasive Fungal infections 4
Barcelona November 5–8th, 1997.
Mullins J., Harvey R., Seaton A. Sources and incidence of airborne Aspergillus fumigatus
(Fres). — Clin Allergy, 1976, vol. 6, p. 209–217.
Murdock B., Falkowski N., Shreiner A. et al. Interleukin-17 drives pulmonary eosinophilia
following repeated exposure to Aspergillus fumigatus conidia. — Infect Immun, 2012,
vol. 80(4), p. 1424–1436.
Murdock B., Shreiner A., McDonald R. et al. Coevolution of TH1, TH2, and TH17 respon
ses during repeated pulmonary exposure to Aspergillus fumigatus conidia. — Infect
Immun, 2011, vol. 79(1), p. 125–135.
-
-
-
-
-
-
th
-
176
Muzio M., Polentarutti N., Bosisio D. et al. Toll-like receptor family and signalling path
way. — Biochem Soc Trans, 2000, vol. 28(5), p. 563–566.
Netea M., Ferwerda G., van der Graaf C. et al. Recognition of fungal pathogens by toll-like
receptors. — Curr Pharm Des, 2006, vol. 12(32), p. 4195–4201.
Netea M., Warris A., Van der Meer J. et al. Aspergillus fumigatus evades immune recogni
tion during germination through loss of TLR4-mediated signal transduction. — J Infect
Dis 2003, vol. 188, p. 320–326.
Netea M., Van der Graaf C., Van der Meer J., Kullberg B. Recognition of fungal pathogens
by Toll-like receptors. — Eur J Clin Microbiol Infect Dis, 2004, vol. 23, p. 672–676.
Niwa H., Yamakawa Y., Kondo K. et al. A high concentration of itraconazole in an aspergil
loma. — Nihon Kyobu Snikkan Gakkai Zasshi, 1996, vol. 34(1), p. 67–70 (Japanese).
Noppen M., Claes I., Maillet B. et al. Three cases of bronchial stump aspergillosis: unusual
clinical presentations and beneficial effect of oral itraconazole. — Eur Resp J, 1995,
vol. 8, p. 477–480.
North M., Miech G., Roegel E., Waitz R. Change of anti-Aspergillus fumigatus serum pre
cipitins during treatment of pulmonary aspergillosis. Apropos of 35 cases. — Rev Im
munol (Paris), 1972, vol. 36(4), p. 177–185 (French).
Nurieva R., Chung Y., Hwang D. et al. Generation of T follicular helper cells is mediated by
interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. — Immunity, 2008,
vol. 29, p. 138–149.
Nurieva R., Chung Y., Martinez G. et al. Bcl6 mediates the development of T follicular hel-
per cells. — Science, 2009, vol. 325, p. 1001–1005.
Obayashi T., Yoshida M., Mori T. et al. Plasma (1,3)-beta-D-glucan measurement in diag-
nosis of invasive deep mycosis and fungal febrile episodes. — Lancet, 1995,
vol. 345(8941), p. 17–20.
Okamoto T., Toyohiro T., Wei B. et al. Regulation of Fungal Infection by a Combination of
Amphotericin B and Peptide 2, a Lactoferrin Peptide That Activates Neutrophils. —
Clin Diagn Lab Immunol 2004, vol. 11(6), p. 1111–1119.
Oshima M., Soda H., Oda H., Watanabe A. A case of allergic bronchopulmonary aspergil
losis caused by Aspergillus terreus. — Nihon Kuobu Shikkai Gakkai Zasshi, 1997,
vol. 35(12), p. 1418–1424.
Panchal N., Bhagat R., Pant C., Shah A. Allergic bronchopulmonary aspergillosis: the
spectrum of computed tomography appearances. — Respir Med, 1997, vol. 91(4),
p. 213–219.
Park S., Lee S., Choi S. et al. Serum and bronchoalveolar lavage fluid galactomannan as
says in patients with pulmonary aspergilloma. — Clin Infect Dis, 2011, vol. 52(7),
p. 149–152.
Pasqualotto A., Powell G., Niven R., Denning D. The effects of antifungal therapy on seve
re asthma with fungal sensitization and allergic bronchopulmonary aspergillosis. —
Respirology, 2009, vol. 14(8), p. 1121–1127.
Pena T., Soubani A., Samavati L. Aspergillus lung disease in patients with sarcoidosis: a
case series and review of the literature. — Lung, 2011, vol. 189(2), p. 167–172.
Pepys J. Hypersensitivity diseases of the lungs due to fungi and organic dusts. — Monogr
Allergy, 1969, vol. 4, p. 1–147.
-
-
-
-
-
-
-
-
177
Perkhofer S., Lugger H., Dierich M., Lass-Florl C. Posaconazole enhances the activity of
amphotericin B against Aspergillus hyphae in vitro. — Antimicrob Agents Chemother,
2007, vol. 51(2), p. 791–793.
Pfeiffer C., Fine J., Safdar N. Diagnosis of invasive aspergillosis using a galactomannan
assay: a meta-analysis. — Clin Infect Dis, 2006, vol. 42(10), p. 1417–1427.
Philippe B., Ibrahim-Granet O., Prevost M. et al. Killing of Aspergillus fumigatus by alveo
lar macrophages is mediated by reactive oxidant intermediates. — Infect Immun
2003, vol. 71(6), p. 3034–3042.
Pickering J., Sant H., Bowles C. et al. Evaluation of a (1->3)-beta-D-glucan assay for diag
nosis of invasive fungal infections. — J Clin Microbiol, 2005, vol. 43(12), p. 5957–5962.
Pimentel J. Pulmonary calcification in the tumor-like form of pulmonary aspergillosis:pul
monary aspergilloma. — Am Rev Respir Dis, 1966, vol. 94(2), p. 208–216.
Plate H., Demischew M. Das Aspergillom als seltene ursado von hamoptysen. — Z Erkrznk
atm, 1990, vol. 174(3), p. 215–218 (German).
Pontier S., Bigay L., Doussau S. et al. Chronic necrotizing pulmonary aspergillosis and an
kylosing spondylarthritis. — Rev Mal Respir, 2000, vol. 17(3), p. 683–686 (French).
Pribila J., Quale A., Mueller K., Shimizu Y. Integrins and T cell-mediated immunity. —
Annu Rev Immunol, 2004, vol. 22, p. 157–180.
Puthothu B., Forster J., Heinze J. et al. Surfactant protein b polymorphisms are associated
with severe respiratory syncytial virus infection, but not with asthma. — BMC Pulm
Med 2007, vol. 7, p. 6.
Raad I., Hanna H., Huaringa A. et al. Diagnosis of invasive pulmonary aspergillosis using
polymerase chain reaction-based detection of aspergillus in BAL. — Chest, 2002,
vol. 121(4), p. 1171–1176.
Raad I., Hanna H., Sumoza D., Albitar M. Polymerase chain reaction on blood for the diag-
nosis of invasive pulmonary aspergillosis in cancer patients. — Cancer, 2002, vol. 94,
p. 1032–1036.
Raad I., Hanna H., Boktour M. et al. Novel antifungal agents as salvage therapy for invasi
ve aspergillosis in patients with hematologic malignancies: posaconazole compared
with high-dose lipid formulations of amphotericin B alone or in combination with cas
pofungin. — Leukemia, 2008, vol. 22(3), p. 496–503.
Radin R., Greenberger P., Patterson R., Ghory A. Mould counts and exacerbations of al
lergic bronchopulmonary aspergillosis. — Clin Allergy, 1983, vol. 13(3), p. 271–275.
Ramirez R. Pulmonary aspergilloma. — New Engl J Med, 1964, vol. 271, p. 1281–1285.
Ravikumar M., Dheenadhayalan V., Rajaram K. et al. Associations of HLA-DRB1, DQB1
and DPB1 alleles with pulmonary tuberculosis in south India. — Tuber Lung Dis,1999,
vol. 79(5), p. 309–317.
Regnard J., Icard P., Nicolosi M. et al. Aspergilloma: a series of 89 surgical cases. — Ann
Thorac Surg, 2000, vol. 69(3), p. 898–903.
Reichenberger F., Habicht J., Gratwohl A., Tamm M. Diagnosis and treatment of invasi
ve pulmonary aspergillosisin neutropenic patients. — Eur Respir J, 2002, vol. 19,
p. 743–755.
Reinwald Ì., Spiess B., Heinz W. et al. Diagnosing pulmohary aspergillosis in patients
with hematological malignancies: A multicenter prospective evaluanion of an Aspegil
lus PCR aasay and a galactomannan ELISA in bronchoalveolar lavage samplies. —
Eur J Haematol, 2012, Jun 1 [Epub ahead of print].
-
-
-
-
-
-
-
-
-
178
Remy J.,Arnaud H., Fardou H. et al. Treatment of hemoptysis by embolisation of bronchial
arteries. — Radiology, 1977, vol. 122, p. 33–37.
Rijnders B., Cornelissen J., Slobbe L. et al. Aerosolized liposomal amphotericin B for the
prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a ran
domized, placebo-controlled trial. — Clin Infect Dis, 2008, vol. 46(9), p. 1401–1408.
Rinaggio J. Tuberculosis. — Dent Clin North Am, 2003, vol. 47(3), p. 449–465.
Roig J., Ruiz J., Puig X. et al. Bronchial stump aspergillosis four years after lobectomy. —
Chest, 1993, vol. 104, p. 295–296.
Romagnani S. Cytokines and chemoattractants in allergic inflammation. — Mol Immunol,
2002, vol. 38(12–13), p. 881–885.
Roselle G., Kauffman C. Case report: invasive pulmonary aspergillosis in a nonimmuno
suppressed patient. — Am J Med Sci, 1978, vol. 276(3), p. 357–361.
Rosenberg A., Brown A. Infection in the cancer patient. — Dis Mon, 1993, vol. 39(7),
p. 505–569.
Rosenberg M., Patterson R., Roberts M., Wang J. The assessment of immunologic and
clinical changes occurring during corticosteroid therapy for allergic bronchopulmonary
aspergillosis. — Am J Med, 1978, vol. 64(4), p. 599–606.
Ruiz Junior R., de Oliveira F., Piotto B. et al. Surgical treatment of pulmonary aspergillo-
ma. — J Bras Pneumol, 2010, vol. 36(6), p. 779–783.
Runza V., Schwaeble W., Mannel D. Ficolins: novel pattern recognition molecules of the
innate immune response. — Immunobiology, 2008, vol. 213(3–4), p. 297–306.
Rzepecki W., Harazda M., Doiezal M. A trial îf isolating a tumor-like form of pulmonary ca-
vities infected with aspergilli. II. Intra and postoperative, morphologic and serologic
data. — Bronches, 1978, vol. 28, p. 87–98.
Saijo S., Ikeda S., Yamabe K. et al. Dectin-2 recognition of alpha-mannans and induction
of Th17 cell differentiation is essential for host defense against Candida albicans. —
Immunity, 2010, vol. 32, p. 681.
Saiton Y., Yamaguchi Y., Fujisawa T. et al. Surgical treatment of pulmonary aspergillo
ma. — J Jap Ass Thorac Surg, 1988, vol. 36(7), p. 1142–1148.
Sales Mda P. Chapter 5 — Aspergillosis: from diagnosis to treatment. — J Bras Pneumol,
2009, vol. 35(12), p. 1238–1244.
Sambatakou H., Dupont B., Lode H., Denning D. Voriconazole treatment for subacute in
vasive and chronic pulmonary aspergillosis. — Am J Med, 2006, vol. 119(6), p. 527.
Sancho J., Ribera J., Rossell A. et al. Unusual invasive bronchial aspergillosis in a patient
with acute limphoblastic leukemia. — Haematologica, 1997, vol. 82(6), p. 701–702.
Sano H., Chiba H., Iwaki D.etal. Surfactant proteins A and D bind CD14 by different mec
hanisms. — J Biol Chem 2000, vol. 275, p. 22442–22451.
Saraceno J., Phelps P., Ferro T. et al. Chronic necrotizing pulmonary aspergillosis: appro
ach to management. — Chest, 1997, vol. 112(2), p. 541–548.
Schaffner A. Host defense in aspergillosis, 1992, p. 98–112 // In J. E. Bennett, R. J. Hay,
P. K. Peterson (ed.), New strategies in fungal disease. — Churchill Livingstone, Edin
burgh, United Kingdom.
Schaffner A., Douglas H., Braude A., Davis C. Killing of Aspergillus spores depends on the
anatomical source of the macrophages. — Infect Immun, 1983, vol. 42, p. 1109–1115.
-
-
-
-
-
-
-
179
Schaffner A., Douglas H., Braude A. Selective protection against conidia by mononuclear
and against mycelia by polymorphonuclear phagocytes in resistance to Aspergil
lus. — J Clin Investig, 1982, vol. 69, p. 617–631.
Schmitt E., Germann T., Goedert S. et al. IL-9 production of naive CD4
+
T cells depends
on IL-2, is synergistically enhanced by a combination of TGF-b and IL-4, and is inhibi
ted by IFN-g. — J Immunol, 1994, vol. 153, p. 3989–3996.
Schonheyder H. Pathogenetic and serological aspects of pulmonary aspergillosis. —
Scand J Infect Dis Suppl, 1987, vol. 51, p. 1–62.
Schreiber J., Struben C., Rosahl W., Amthor M. Hypersensitivity alveolitis induced by en
dogenous candida species. — Eur J Med Res, 2000, vol. 5(3), p. 126.
Schutte B., Mitros J., Bartlett J. et al. Discovery of five conserved beta-defensin gene clus
ters using a computational search strategy. — Proc Natl Acad Sci USA 2002, 99(4),
p. 2129–2133.
Schwartz H., Greenberger P. The prevalence of allergic bronchopulmonary aspergillosis
in patients with asthma, determined by serologic and radiologic criteria in patients at
risk.
Seder R., Gazzinelli R., Sher A., Paul W. Interleukin 12 acts directly on CD4
+
T cells to en
hance priming for interferon ã production and diminishes interleukin 4 inhibition of such
priming. — Proc Natl Acad Sci USA, 1993, vol. 90, p. 10188–10192.
Severo L., Geyer G., Porto N. Pulmonary Aspergillus intracavitary colonization (PAIC). —
Mycopathologia, 1990, vol. 112(2), p. 93–104.
Shevach E. Regulatory T cells in autoimmmunity. — Annu Rev Immunol, 2000, vol. 18,
p. 423–449.
Smeenk F., Klinkhamer P., Breed W. et al. Opportunistic lung infections in patients with
chronic obstructive lung disease, vol. a side effect of inhalation corticosteroids? —
Ned Tijdschr Geneeskd, 1996, vol. 140(2), p. 94–98 (Dutch).
Smith F., Beneck D. Localized Aspergillus infestation in primary lung carcinoma. Clinical
and pathological contrasts with post-tuberculous intracavitary aspergilloma. — Chest,
1991, vol. 100(2), p. 554–556.
Smith N., Denning D. Underlying conditions in chronic pulmonary aspergillosis including
simple aspergilloma. — Eur Respir J, 2011, vol. 37(4), p. 865–872.
Stanzani M., Battista G., Sassi C. et al. Computed tomographic pulmonary angiography
for diagnosis of invasive mold diseases in patients with hematological malignanci
es. — Clin Infect Dis, 2012, vol. 54(5), p. 610–616.
Steele C., Rapaka R., Metz A. et al. The beta-glucan receptor dectin-1 recognizes specific
morphologies of Aspergillus fumigatus. — PLoS Pathog, 2005, vol. 1(4), p. 42.
Stevens D., Kan V., Judson M. et al. Practice Guidelines for diseases caused by Aspergil
lus. — Clinical Infections Diseases, 2000, vol. 30, p. 676–709.
Suga M., Yamasaki H., Nakagawa K. et al. Mechanisms accounting for granulomatous
responses in hypersensitivity pneumonitis. — Sarcoidosis Vasc Diffuse Lung Dis,
1997, vol. 14(2), p. 131–138.
Sugawara I., Shimamine T., Okudaira M. Generalized aspergillosis showing a granuloma
tous pattern. — Acta Pathol Jpn, 1979, vol. 29(5), p. 811–818.
Swain S., Weinberg A., English M., Huston G. IL-4 directs the developmentof Th2-like hel
per effectors. — J Immunol, 1990, vol. 145, p. 3796–3806.
-
-
-
-
-
-
-
-
-
180
Соседние файлы в предмете [НЕСОРТИРОВАННОЕ]